307 related articles for article (PubMed ID: 32910913)
21. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
[TBL] [Abstract][Full Text] [Related]
22. Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.
Giuffrida FMA; Moises RS; Weinert LS; Calliari LE; Manna TD; Dotto RP; Franco LF; Caetano LA; Teles MG; Lima RA; Alves C; Dib SA; Silveiro SP; Dias-da-Silva MR; Reis AF;
Diabetes Res Clin Pract; 2017 Jan; 123():134-142. PubMed ID: 28012402
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
[TBL] [Abstract][Full Text] [Related]
24. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
25. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of p.Pro409His variant in HNF1A, a hypomorphic mutation involved in pancreatic β-cell dysfunction.
Nocera D; Menniti M; Belviso S; Bond HM; Lanzillotta D; Spoleti CB; Guagliardi MR; Malatesta P; Trapasso F; Irace C; Perrotti N; Iuliano R
Acta Diabetol; 2019 Aug; 56(8):883-888. PubMed ID: 30963309
[TBL] [Abstract][Full Text] [Related]
27. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
28. New clinical screening strategy to distinguish
Ma Y; Gong S; Wang X; Cai X; Xiao X; Gu W; Yang J; Zhong L; Xiao J; Li M; Liu W; Zhang S; Zhou X; Li Y; Zhou L; Zhu Y; Luo Y; Ren Q; Huang X; Gao X; Zhang X; Zhang R; Chen L; Wang F; Wang Q; Hu M; Han X; Ji L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32238361
[TBL] [Abstract][Full Text] [Related]
29. Variants influencing age at diagnosis of HNF1A-MODY.
Ludwig-Słomczyńska AH; Seweryn MT; Radkowski P; Kapusta P; Machlowska J; Pruhova S; Gasperikova D; Bellanne-Chantelot C; Hattersley A; Kandasamy B; Letourneau-Freiberg L; Philipson L; Doria A; Wołkow PP; Małecki MT; Klupa T
Mol Med; 2022 Sep; 28(1):113. PubMed ID: 36104811
[TBL] [Abstract][Full Text] [Related]
30. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
[TBL] [Abstract][Full Text] [Related]
32. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
Pal A; Farmer AJ; Dudley C; Selwood MP; Barrow BA; Klyne R; Grew JP; McCarthy MI; Gloyn AL; Owen KR
Diabetes Care; 2010 Feb; 33(2):252-7. PubMed ID: 19933992
[TBL] [Abstract][Full Text] [Related]
34. Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.
Weinert LS; Silveiro SP; Giuffrida FM; Cunha VT; Bulcão C; Calliari LE; Della Manna T; Kunii IS; Dotto RP; Dias-da-Silva MR; Reis AF
Diabetes Res Clin Pract; 2014 Nov; 106(2):e44-8. PubMed ID: 25174781
[TBL] [Abstract][Full Text] [Related]
35. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
[TBL] [Abstract][Full Text] [Related]
37. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
[TBL] [Abstract][Full Text] [Related]
38. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.
Bellanné-Chantelot C; Carette C; Riveline JP; Valéro R; Gautier JF; Larger E; Reznik Y; Ducluzeau PH; Sola A; Hartemann-Heurtier A; Lecomte P; Chaillous L; Laloi-Michelin M; Wilhem JM; Cuny P; Duron F; Guerci B; Jeandidier N; Mosnier-Pudar H; Assayag M; Dubois-Laforgue D; Velho G; Timsit J
Diabetes; 2008 Feb; 57(2):503-8. PubMed ID: 18003757
[TBL] [Abstract][Full Text] [Related]
39. Circulating CD36 is reduced in HNF1A-MODY carriers.
Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
[TBL] [Abstract][Full Text] [Related]
40. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
